Alvarez & Marsal Launches AI powered Digital Agency A&MPLIFY
Led in North America by Alvarez & Marsal Managing Director Bob Ghafouri, A&MPLIFY helps clients…
Led in North America by Alvarez & Marsal Managing Director Bob Ghafouri, A&MPLIFY helps clients…
Pomona Investment Fund will offer plan participants access to long-term capital-appreciation investing WINDSOR, Conn.–(BUSINESS WIRE)–Voya…
Esri Press Releases Protecting the People: GIS for Law Enforcement REDLANDS, Calif.–(BUSINESS WIRE)–Location intelligence is…
Secure checkouts, accurate stock, and quick load speed are the top features consumers expect when…
The product was recognized in the Apps & Software category LONDON, Nov. 10, 2022 (GLOBE…
— Median overall survival (OS) for patients with metastatic, microsatellite stable colorectal cancer (MSS-CRC) who…
Closed private placement in August 2022, with net proceeds of approximately $8.7 million Announced plans…
Hamilton, Bermuda, Nov. 10, 2022 (GLOBE NEWSWIRE) — • TIDES Europe Event will be held…
Glen Rock, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
-Advancing development of herbicide tolerant Camelina- -Building commercial seed inventory available to growers in 2023…
MIAMI, Nov. 10, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
– Topline data from Phase 1/2 clinical trial of INZ-701 in ENPP1 Deficiency on track…
HOUSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
– Median Overall Survival for GPS Combination (GPS in Combination with Keytruda) was 18.4 Months…
KELOWNA, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB:…
Successful combination of technologies will expand the opportunities for IMUNON’s DNA-based modality and broaden applications…
Company completed a public offering for aggregate gross proceeds of $16.8 million Majority of clinical…
Media Release COPENHAGEN, Denmark; November 10, 2022 Genmab A/S (Nasdaq: GMAB) announced today that its…
Common Stock Will Begin Trading on Split-Adjusted Basis on November 11, 2022 BOSTON, Nov. 10,…
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…